These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3839995)

  • 21. Saframycin S, a new saframycin group antibiotic.
    Mikami Y; Yokoyama K; Tabeta H; Nakagaki K; Arai T
    J Pharmacobiodyn; 1981 Apr; 4(4):282-6. PubMed ID: 7264873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production, isolation and chemical characterization of mimosamycin.
    Fukumi H; Maruyama F; Yoshida K; Arai M
    J Antibiot (Tokyo); 1978 Sep; 31(9):847-9. PubMed ID: 711627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biosynthesis of vineomycins A1 and B2.
    Imamura N; Kakinuma K; Ikekawa N; Tanaka H; Omura S
    J Antibiot (Tokyo); 1982 May; 35(5):602-8. PubMed ID: 7107524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some chemotherapeutic properties of two new antitumor antibiotics, saframycins A and C.
    Arai T; Takahashi K; Ishiguro K; Mikami Y
    Gan; 1980 Dec; 71(6):790-6. PubMed ID: 7274625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstruction of the saframycin core scaffold defines dual Pictet-Spengler mechanisms.
    Koketsu K; Watanabe K; Suda H; Oguri H; Oikawa H
    Nat Chem Biol; 2010 Jun; 6(6):408-10. PubMed ID: 20453862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chrolactomycin, a novel antitumor antibiotic produced by Streptomyces sp.
    Nakai R; Kakita S; Asai A; Chiba S; Akinaga S; Mizukami T; Yamashita Y
    J Antibiot (Tokyo); 2001 Oct; 54(10):836-9. PubMed ID: 11776440
    [No Abstract]   [Full Text] [Related]  

  • 27. Structure of saframycin D, a new dimeric isoquinolinequinone antibiotic.
    Kubo A; Saito N; Kitahara Y; Takahashi K; Yazawa K; Arai T
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):440-2. PubMed ID: 3594668
    [No Abstract]   [Full Text] [Related]  

  • 28. [Establishing the structure of anthracyclinones produced by Streptomyces griseoruber].
    Bakina EV; Iartseva IV; Povarov LS; Aleksandrova LG; Tulemisova KA; Mamonova LP; Preobrazhenskaia MN
    Bioorg Khim; 1989 Oct; 15(10):1423-30. PubMed ID: 2631686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duocarmycins, potent antitumor antibiotics produced by Streptomyces sp. structures and chemistry.
    Yasuzawa T; Muroi K; Ichimura M; Takahashi I; Ogawa T; Takahashi K; Sano H; Saitoh Y
    Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):378-91. PubMed ID: 7774022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-step construction of the pentacyclic skeleton of saframycin A from a "Trimer" of alpha-amino aldehydes.
    Myers AG; Kung DW
    Org Lett; 2000 Sep; 2(19):3019-22. PubMed ID: 10986097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urdamycins, new angucycline antibiotics from Streptomyces fradiae. IV. Biosynthetic studies of urdamycins A-D.
    Rohr J; Beale JM; Floss HG
    J Antibiot (Tokyo); 1989 Jul; 42(7):1151-7. PubMed ID: 2753820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Formation of an antibiotic of the siomycin group by a Streptomyces corchorusii 1401 culture].
    Gauze GF; Preobrazhenskaia TP; Ukholina RS; Maksimova TS; Brazhnikova MG
    Antibiotiki; 1983 Sep; 28(9):643-7. PubMed ID: 6638977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on cochleamycins, novel antitumor antibiotics. III. Biosyntheses of cochleamycins: incorporation of 13C- and 2H-labeled compounds into cochleamycins.
    Shindo K; Sakakibara M; Kawai H; Seto H
    J Antibiot (Tokyo); 1996 Mar; 49(3):249-52. PubMed ID: 8626239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trisarubicinol, new antitumor anthracycline antibiotic.
    Yoshimoto A; Matsuzawa Y; Matsushita Y; Oki T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Nov; 34(11):1492-4. PubMed ID: 7319909
    [No Abstract]   [Full Text] [Related]  

  • 35. SW-163C and E, novel antitumor depsipeptides produced by Streptomyces sp. II. Structure elucidation.
    Takahashi K; Koshino H; Esumi Y; Tsuda E; Kurosawa K
    J Antibiot (Tokyo); 2001 Aug; 54(8):622-7. PubMed ID: 11592498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New antitumor antibiotic, LL-C10037 alpha. Fermentation, isolation and structure determination.
    Lee MD; Fantini AA; Morton GO; James JC; Borders DB; Testa RT
    J Antibiot (Tokyo); 1984 Oct; 37(10):1149-52. PubMed ID: 6548735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precursors in the biosynthesis of FR-900482, a novel antitumor antibiotic produced by Streptomyces sandaensis.
    Fujita T; Takase S; Otsuka T; Terano H; Kohsaka M
    J Antibiot (Tokyo); 1988 Mar; 41(3):392-4. PubMed ID: 3366695
    [No Abstract]   [Full Text] [Related]  

  • 38. Biosynthesis of the antitumor antibiotic CC-1065 by Streptomyces zelensis.
    Hurley LH; Rokem JS
    J Antibiot (Tokyo); 1983 Apr; 36(4):383-90. PubMed ID: 6406412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directed biosynthesis of 5"-fluoropactamycin in Streptomyces pactum.
    Adams ES; Rinehart KL
    J Antibiot (Tokyo); 1994 Dec; 47(12):1456-65. PubMed ID: 7844040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymmetric synthesis and cytotoxicity of (-)-saframycin A analogues.
    Dong W; Liu W; Yan Z; Liao X; Guan B; Wang N; Liu Z
    Eur J Med Chem; 2012 Mar; 49():239-44. PubMed ID: 22284268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.